Abstract
A statistical analysis was performed on the possible influence of injection sites on botulinum toxin A (BAT) treatment of essential blepharospasm. For this purpose, two groups (a total of 60 patients) were evaluated. The first group was treated with three suprabrow injections and the second one with five lid injections. The amount of BAT was the same in the two groups. Clinical results of the two different techniques appeared to be superimposable. Potentially, lid injection may induce more side effects. This was not, however, noted in our study. This is the first comparative study on the role of injection sites for BAT.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
